What the Study Found
One of the largest investigations yet into coffee and liver health reports that people who drank more coffee had lower rates of cirrhosis, liver cancer and liver-related death, and that their livers and blood looked measurably different too.
The analysis, published in Clinical Gastroenterology and Hepatology, followed 354,957 UK Biobank participants who had neither cirrhosis nor hepatocellular carcinoma at enrollment for a median of 13 years. Compared with people who drank no coffee, those reporting five or more cups a day had a 32% lower risk of cirrhosis, a 47% lower risk of liver cancer and a 42% lower risk of liver-related death.
The effect was not limited to heavy drinkers. One to two cups a day was associated with roughly 20% lower cirrhosis risk and 31% lower liver-related mortality, with the association appearing strongest around three to four cups.
The word doing the work in every one of those sentences is "associated." This is an observational cohort, and it cannot establish that coffee caused the difference.
Why This Matters
Chronic liver disease is common, frequently silent until late, and driven substantially by conditions many households already manage: excess weight, type 2 diabetes and alcohol use.
A finding that a widely consumed, inexpensive beverage tracks with better liver outcomes is worth reporting for that reason. It is also worth reporting carefully, because the gap between "people who drink coffee have healthier livers" and "drinking coffee will give you a healthier liver" is exactly where health coverage usually goes wrong.
The practical takeaway is narrower than the headline numbers suggest, and it is genuinely useful: for an adult who already drinks and tolerates coffee, nothing here argues for cutting back.
What Makes This Study Different
Most previous coffee and liver research counted diagnoses. This one looked inside.
In a subgroup of 28,961 participants who underwent magnetic resonance imaging, researchers measured liver fat, liver iron, and fibroinflammation. People who drank more coffee tended to show lower levels of all three. Excess liver fat is the foundation of fatty liver disease, which can progress through fibrosis to cirrhosis and cancer, and elevated liver iron is associated with oxidative stress.
In 44,633 participants, the team measured roughly 2,900 circulating proteins. Coffee drinkers showed higher levels of proteins associated with healthy liver function and lower levels of proteins linked to scarring and inflammation.
Hyunseok Kim, MD, MPH, PhD, the corresponding author and a hepatologist at Cedars-Sinai, noted that earlier studies were mostly smaller or examined only one piece of the puzzle. Having clinical outcomes, imaging, and molecular data pointing in the same direction is what the authors argue strengthens the case for a real biological effect.
What the Evidence Shows and What It Does Not
The authors listed their own limitations plainly, and they matter.
Coffee intake was self-reported through a questionnaire, which introduces error. The study cannot rule out unmeasured confounding, meaning some other characteristic of coffee drinkers could explain the pattern. It also cannot rule out reverse causation, in which people with early undiagnosed liver disease drink less coffee because they feel unwell, making coffee drinkers look healthier by comparison.
The MRI subgroup was healthier than the full cohort, and the population was predominantly of European ancestry, which limits how far the findings generalize. The authors also said the blood protein findings require experimental studies before anyone can claim to have identified the mechanism.
The confounders most likely to matter for readers are the obvious ones. Alcohol use, body weight and overall diet quality are the dominant drivers of liver disease risk, and the analysis adjusted for alcohol use, body mass index category, diabetes, hypertension, smoking, deprivation and a genetic variant associated with fatty liver disease. Statistical adjustment reduces confounding. It does not eliminate it.
One subgroup stood out: among people with diabetes, the association between coffee and lower cirrhosis risk was somewhat weaker, though the associations with liver cancer and liver-related mortality persisted.
Who This Applies To
The population studied was middle-aged and older adults in the United Kingdom, most of European ancestry, without existing cirrhosis or liver cancer. Findings may not transfer to people with established liver disease, to younger adults, or to populations with different genetic backgrounds and dietary patterns.
People who should not increase coffee intake on the strength of this study include anyone with an arrhythmia or heart condition where caffeine is a concern, people with poorly controlled anxiety or insomnia, people with certain gastrointestinal conditions, and anyone whose clinician has advised limiting caffeine. Pregnant readers should follow existing guidance on caffeine limits rather than this study.
What This Does Not Change
No amount of coffee offsets heavy or sustained alcohol consumption, and the researchers did not suggest otherwise.
The investigators specifically declined to frame their results as a reason to push intake toward five or more cups a day. That restraint is worth carrying into any decision a reader makes, particularly since the associations were already substantial at three to four cups.
Adding significant sugar or high-calorie mixers to coffee introduces its own metabolic burden, which works against the outcome the study measured. Current medical guidance for liver health has not changed.
What You Can Do Now
For people who already drink coffee and tolerate it well, this is a reason for reassurance rather than action. Keeping it relatively low in added sugar is a reasonable adjustment supported by broader nutrition evidence.
The steps that actually move liver risk are the unglamorous ones: limiting alcohol, managing weight, controlling blood sugar and blood pressure, staying physically active, and getting vaccinated against hepatitis B. Anyone with risk factors for liver disease should ask a clinician whether liver enzyme testing or imaging is appropriate, since early disease is usually symptomless.
No one should start drinking coffee for liver protection based on an observational study, and no one should stop a prescribed medication or delay evaluation because of it.
Funding and Conflicts
The study received no external funding. Ju Dong Yang, MD, one of the authors, reported consulting relationships with several companies. The remaining authors reported no relevant conflicts. Readers evaluating any nutrition finding should know who paid for it, and in this case no beverage industry funding was reported.
What Happens Next
The research team plans to identify which bioactive compounds in coffee might be responsible and to investigate the molecular pathways involved in inflammation and fibrosis. The investigators also see potential for MRI-based liver biomarkers to serve as non-invasive tools for testing whether dietary changes alter liver biology before disease appears, though prospective intervention trials would be needed to confirm that. MedicalDaily will report if intervention trial results emerge.
The Bottom Line
The newest confirmed finding is a graded association between coffee intake and lower cirrhosis, liver cancer, and liver-related death across 355,000 people, supported by imaging and blood protein data. The people it most concerns are adults with liver disease risk factors. The reasonable response is to keep drinking coffee if you already do, and to address alcohol, weight and blood sugar, which are the established drivers. The central uncertainty is whether coffee causes any of this, and this study cannot answer that.
